First Bundibugyo Ebola vaccine to start human trials in the UK

Published on

14/07/2026 - 12:35 GMT+2

The University of Oxford’s Vaccine Group has launched the world’s first human clinical trial of a vaccine against Bundibugyo Ebolavirus amid the ongoing outbreak in the Democratic Republic of the Congo and Uganda.

The Phase I clinical trial will take place in Oxford and will assess the safety and immune response of the vaccine in 50 healthy adults aged between 18 and 55.

“Every step that brings a safe and effective vaccine closer helps strengthen our ability to protect vulnerable communities, save lives and bring this outbreak under control,” said Nicole Lurie from the Coalition for Epidemic Preparedness Innovations (CEPI), adding that the University of Oxford’s work is a “pivotal milestone in the response effort”.